Peter Abrahamsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter Abrahamsson has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Gunilla Andersson
2 shared publications- Ava Minston
Department of Orofacial Pain and Jaw Function, Postgraduate Dental Education Center Public Dental Health Service Örebro Sweden
1 shared publication B. Chen
1 shared publicationDan-Åke Wälivaara
1 shared publication- Daniel Ovesson
Department of Orofacial Pain and Jaw Function Karlstad Hospital Karlstad Sweden
1 shared publication Dan‐Åke Wälivaara
Hallands Hospital Maxillofacial Unit SE Sweden
1 shared publication
Latest Publications
- Open Access
- 29 December 2024
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 52 (5) , 587-596
Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study
Background: Botulinum toxin Type A (BTX‐A) is increasingly used in the management of myofascial pain; however, the evidence to support this treatment modality is still inconclusive.Objective: To evaluate the change in days with functional jaw pain after one session of BTX‐A or placebo injections into the masseter and temporalis muscles in subjects with jaw myalgia. The hypothesis was that BTX‐A is effective in reducing the number of days with functional jaw pain.Methods: This was a randomised, double‐blind, parallel group study in subjects with jaw myalgia. After randomisation, BTX‐A or placebo injections were made in the masseter and temporalis muscles. The number of days with jaw pain on function was evaluated after 2 months. Adverse events were registered.Results: Twenty‐three subjects were randomly assigned to BTX‐A and 22 to placebo. Between baseline and the 2‐month follow‐up, the number of days with jaw pain at function changed from a median (interquartile range) of 14 (4) to 10.5 (6) days in the BTX‐A group and from 14.0 (1.5) to 14 (5) in the saline group (p < 0.585). Adverse events were mild and transient and similar in the two groups.Conclusion: A single treatment of BTX‐A injections in the masseter and temporalis muscles was not effective in treating jaw myalgia. However, an adequately powered study might provide sufficient support for efficacy.
- 29 December 2024
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 52 (5) , 587-596
Open AccessEffect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study
Background: Botulinum toxin Type A (BTX‐A) is increasingly used in the management of myofascial pain; however, the evidence to support this treatment modality is still inconclusive.Objective: To evaluate the change in days with functional jaw pain after one session of BTX‐A or placebo injections into the masseter and temporalis muscles in subjects with jaw myalgia. The hypothesis was that BTX‐A is effective in reducing the number of days with functional jaw pain.Methods: This was a randomised, double‐blind, parallel group study in subjects with jaw myalgia. After randomisation, BTX‐A or placebo injections were made in the masseter and temporalis muscles. The number of days with jaw pain on function was evaluated after 2 months. Adverse events were registered.Results: Twenty‐three subjects were randomly assigned to BTX‐A and 22 to placebo. Between baseline and the 2‐month follow‐up, the number of days with jaw pain at function changed from a median (interquartile range) of 14 (4) to 10.5 (6) days in the BTX‐A group and from 14.0 (1.5) to 14 (5) in the saline group (p < 0.585). Adverse events were mild and transient and similar in the two groups.Conclusion: A single treatment of BTX‐A injections in the masseter and temporalis muscles was not effective in treating jaw myalgia. However, an adequately powered study might provide sufficient support for efficacy.
- Open Access
- 1 June 2017
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 3 (3) , 100-106
Vertical bone augmentation with titanium granule blocks in rabbit calvaria
To determine whether it is possible to vertically augment bone utilizing a block graft from compressed titanium granules mainly used previously for contained bone defects and to determine whether there exists a difference in osteoconductive properties between the white and the grey granules. In 11 rabbits, 4 titanium blocks were inserted on each rabbit's skull bone according to a randomized scheme. These blocks were made from standardized compressed titanium granules. Type A: PTG grey, small granules (Pourus Titanium Granules, Tigran, Malmö, Sweden); Type B: PTG grey, large granules; Type C: PTG white, small granules; Type D: PTG white large granules. After 12 weeks, the animals were sacrificed and specimens were collected for histology and μCT scanning. From both the μCT and histology, it can be said that bone formation was successfully achieved for all groups, and the granules maintained their volume. The histomorphometric BA (bone area) evaluation in the entire grafted area presented that there were no statistical differences between all groups tested. The lowest 1/4 BA in contact with the rabbit skull presented that groups A and C presented the highest mean BA, and group A presented significantly higher BA than that of group D (p = 0,049). No significant differences were noted between groups A, B and C. Within the limitation of this study, no differences were noted between small white or grey PTG blocks. The large granules presented less bone ingrowth area compared to the small granules and this trend was regardless of the different PTG types. The entire grafted area was not filled with new bone suggesting that bone migration occurred mostly from the existing cortical bone side suggesting contact osteogenesis.
- 1 June 2017
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 3 (3) , 100-106
Open AccessVertical bone augmentation with titanium granule blocks in rabbit calvaria
To determine whether it is possible to vertically augment bone utilizing a block graft from compressed titanium granules mainly used previously for contained bone defects and to determine whether there exists a difference in osteoconductive properties between the white and the grey granules. In 11 rabbits, 4 titanium blocks were inserted on each rabbit's skull bone according to a randomized scheme. These blocks were made from standardized compressed titanium granules. Type A: PTG grey, small granules (Pourus Titanium Granules, Tigran, Malmö, Sweden); Type B: PTG grey, large granules; Type C: PTG white, small granules; Type D: PTG white large granules. After 12 weeks, the animals were sacrificed and specimens were collected for histology and μCT scanning. From both the μCT and histology, it can be said that bone formation was successfully achieved for all groups, and the granules maintained their volume. The histomorphometric BA (bone area) evaluation in the entire grafted area presented that there were no statistical differences between all groups tested. The lowest 1/4 BA in contact with the rabbit skull presented that groups A and C presented the highest mean BA, and group A presented significantly higher BA than that of group D (p = 0,049). No significant differences were noted between groups A, B and C. Within the limitation of this study, no differences were noted between small white or grey PTG blocks. The large granules presented less bone ingrowth area compared to the small granules and this trend was regardless of the different PTG types. The entire grafted area was not filled with new bone suggesting that bone migration occurred mostly from the existing cortical bone side suggesting contact osteogenesis.
- 1 October 2012
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 70 (10) , e521-e530
Periosteal Expansion Before Local Bone Reconstruction Using a New Technique for Measuring Soft Tissue Profile Stability: A Clinical Study
- 1 October 2012
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 70 (10) , e521-e530
Periosteal Expansion Before Local Bone Reconstruction Using a New Technique for Measuring Soft Tissue Profile Stability: A Clinical Study
- 1 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e934-e934a
934 Androgen receptor expression is induced by docetaxel in prostate cancer cells
- 1 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e934-e934a
934 Androgen receptor expression is induced by docetaxel in prostate cancer cells
- 10 November 2010
- Published by Wiley in Clinical Oral Implants Research
- Vol. 21 (12) , 1404-1410
Onlay bone grafting of the mandible after periosteal expansion with an osmotic tissue expander: an experimental study in rabbits
Objectives: To evaluate the space‐maintaining capacity of a titanium mesh or a bioresorbable mesh after periosteal expansion and to assess bone formation under a titanium mesh or a bioresorbable mesh on the lateral border of the mandible by qualitative and quantitative histological analysis.Material and methods: In 13 rabbits, a self‐inflatable soft tissue expander was placed intraorally, bilaterally under the mandibular periosteum via an extra oral approach. After 2 weeks, the expanders were removed and a particulated onlay bone graft was placed and covered by a titanium mesh or a bioresorbable mesh. After 3 months, the animals were sacrificed and specimens were collected for histology.Results: The osmotic soft tissue expander created a subperiosteal pocket and a ridge of new bone had formed at the edges of the expanded periosteum in all sites. After the healing period of 3 months, soft tissue dehiscence was recorded in two of the sites with bioresorbable meshes. The mean bone fill was 65% under the titanium mesh and 85% under the bioresorbable mesh (PConclusion: This study confirms that an osmotic soft tissue expander creates a surplus of periosteum and soft tissue and that new bone can be generated under a titanium mesh or bioresorbable mesh. To cite this article: Abrahamsson P, Isaksson S, Gordh M, Andersson G. Onlay bone grafting of the mandible after periosteal expansion with an osmotic tissue expander: an experimental study in rabbits. Clin. Oral Impl. Res21, 2010; 1404–1410. doi: 10.1111/j.1600‐0501.2010.01967.x
- 10 November 2010
- Published by Wiley in Clinical Oral Implants Research
- Vol. 21 (12) , 1404-1410
Onlay bone grafting of the mandible after periosteal expansion with an osmotic tissue expander: an experimental study in rabbits
Objectives: To evaluate the space‐maintaining capacity of a titanium mesh or a bioresorbable mesh after periosteal expansion and to assess bone formation under a titanium mesh or a bioresorbable mesh on the lateral border of the mandible by qualitative and quantitative histological analysis.Material and methods: In 13 rabbits, a self‐inflatable soft tissue expander was placed intraorally, bilaterally under the mandibular periosteum via an extra oral approach. After 2 weeks, the expanders were removed and a particulated onlay bone graft was placed and covered by a titanium mesh or a bioresorbable mesh. After 3 months, the animals were sacrificed and specimens were collected for histology.Results: The osmotic soft tissue expander created a subperiosteal pocket and a ridge of new bone had formed at the edges of the expanded periosteum in all sites. After the healing period of 3 months, soft tissue dehiscence was recorded in two of the sites with bioresorbable meshes. The mean bone fill was 65% under the titanium mesh and 85% under the bioresorbable mesh (PConclusion: This study confirms that an osmotic soft tissue expander creates a surplus of periosteum and soft tissue and that new bone can be generated under a titanium mesh or bioresorbable mesh. To cite this article: Abrahamsson P, Isaksson S, Gordh M, Andersson G. Onlay bone grafting of the mandible after periosteal expansion with an osmotic tissue expander: an experimental study in rabbits. Clin. Oral Impl. Res21, 2010; 1404–1410. doi: 10.1111/j.1600‐0501.2010.01967.x